Germany’s vaccine advisory committee on Thursday recommended that Pfizer-BioNTech’s COVID-19 vaccine should only be given to adolescents with pre-existing conditions that raise their risk of getting seriously sick if they get the pulmonary illness.
The advisory committee, called STIKO, said in a statement that it was not currently recommending the COVID-19 vaccine be given to those aged 12–17 without pre-existing conditions, even though the European health regulator in May approved the Pfizer-BioNTech shot for use in children as young as 12 under a conditional marketing authorization.
